본문 바로가기
KERD
논문KCI 등재

항암화학요법과 통합의학치료를 병행하여 부분 관해 된 간전이 동반 말기 췌장암 1례

A Case Report of Partial Remission of End-stage Pancreatic Cancer Patient with Liver Metastasis Treated with Chemotherapy and Integrated Medicine Therapy

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: This study reports on the effect of Integrative Medicine Therapy (IMT) on a patient with pancreatic cancer with liver metastasis. Methods: One pancreatic cancer with liver metastasis patient was treated using IMT in conjunction with Gemcitabine/Abraxane since September 2019. The cycle was repeated every four weeks for a total of 11 times. At the same time, the patient was treated with IMT. Tumor size was measured by scanning with Computed Tomography (CT). Adverse events were evaluated using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), version 5.0. Results: After treatment with Gemcitabine/Abraxane and IMT for eight months, the size of the body and tail of the cancer tumor and several hepatic metastatic regions decreased (partial response, [PR]), size, and number of multiple nodules in both lungs decreased. No evidence of newly developed metastatic lesions was found. The patient has maintained a good treatment outcome and has shown prolonged overall survival. Conclusions: This case demonstrates that treatment with IMT may have substantial benefits for patients with end-stage pancreatic cancer.

Abstract

Objectives: This study reports on the effect of Integrative Medicine Therapy (IMT) on a patient with pancreatic cancer with liver metastasis. Methods: One pancreatic cancer with liver metastasis patient was treated using IMT in conjunction with Gemcitabine/Abraxane since September 2019. The cycle was repeated every four weeks for a total of 11 times. At the same time, the patient was treated with IMT. Tumor size was measured by scanning with Computed Tomography (CT). Adverse events were evaluated using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), version 5.0. Results: After treatment with Gemcitabine/Abraxane and IMT for eight months, the size of the body and tail of the cancer tumor and several hepatic metastatic regions decreased (partial response, [PR]), size, and number of multiple nodules in both lungs decreased. No evidence of newly developed metastatic lesions was found. The patient has maintained a good treatment outcome and has shown prolonged overall survival. Conclusions: This case demonstrates that treatment with IMT may have substantial benefits for patients with end-stage pancreatic cancer.

참고문헌 (32)

  1. Siegel RL, "Cancer statistics 2018", CA Cancer J Clin, 68(1), pp.7~30 (2018)
  2. "National Center Information Cancer"[URL]
  3. 박주경, "수술 불가능한 췌장암 환자에서 생존율 및 예후 인자 분석", 대한내과학회지, 72(2), pp.151~161 (2007), 대한내과학회
  4. Kleeff J, "Pancreatic cancer", Nature Reviews, 2, pp.16023~ (2016)
  5. Von Hoff DD, "Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine", N Engl J Med, 369(18), pp.1691~1703 (2013)
  6. Reyes-Gibby CC, "Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation", J Pain Symptom Manage, 34(3), pp.244~252 (2007)
  7. Renia M, "Quality of life assessment in advanced pancreatic adenocarcinoma : results from a Phase III randomized trial", Pancreatology, 6(5), pp.454~463 (2006)
  8. 장성환, "한약치료와 표적항암요법(아피니토)을 병행하여 부분 관해 된 신세포암 간전이 환자 1례", 대한암한의학회지, 22(2), pp.13~24 (2017), 대한암한의학회[DOI]
  9. Jin YJ, "A Case of Improvement of Metastatic Ovarian and Endometrial Cancer Treated by Integrative Medicine Therapy Combined with Chemotherapy", J of Kor Traditional Oncology, 19(1), pp.33~41 (2014)
  10. Eisenhauer EA, "New response evaluation criteria in solid tumours:Revised RECIST guideline(version 1.1)", Eur J Cancer, 45(2), pp.228~247 (2009)
  11. "Common Terminology Criteria for Adverse Events(CTCAE) v.5.0" (2017)[URL]
  12. Sharma S, "Tumor markers in clinical practice:General principles and guidelines", Indian journal of medical and paediatric oncology official journal of Indian Society of Medical & Paediatric Oncology, 30(1), pp.1~8 (2009)
  13. "Plymouth Meeting"[URL]
  14. 조영덕, "췌장암의 증상 경감을 위한 보존요법", 대한소화기학회지, 51(2), pp.119~126 (2008), 대한소화기학회
  15. Lockhart AC, "Treatment for pancreatic cancer : current therapy and continued progress", Gastroenterology, 128(6), pp.1642~1654 (2005)
  16. Schmitz KH, "American College of Sports Medicine roundtable on exercise guidelines for cancer survivors", Med Sci Sports Exerc, 42(7), pp.1409~1426 (2010)
  17. Li M, "Different Survival Benefits of Chinese Medicine for Pancreatic Cancer :How to Choose?", Chin J Integr Med, 24(3), pp.178~184 (2018)
  18. 김진목, "통합암치료 로드맵", pp.47~50 (2014), 서현사
  19. Levy MH, "Palliative care", J Natl Compr Can c Netw, 10(10), pp.1284~1309 (2012)
  20. Smith TJ, "American Society of Clinical Oncology Provisional Clinical Opinion :the integration of palliative care in to standard oncology care", J Clin Oncol, 30(8), pp.880~887 (2012)
  21. Herbology Editorial Committee of Nationwide College of Korean Medicine, "Boncho-hak", pp.439~ (1991), Younglimsa
  22. Jang HJ, "Molecular mechanism by which Resina Toxicodendrii induces apoptosis and suppresses chemoresistance in MCF-7", DOX cells, Graduate School of Korean Medicine, Kyunghee University, 2017
  23. 박소정, "건칠계복정으로 치료한 임상적 진행성 폐암 환자 1례", 대한암한의학회지, 20(1), pp.23~29 (2015), 대한암한의학회
  24. 한가진, "유방암에 대한 한양방 병용 치료 증례 보고 1례", 대한한방내과학회지, 38(5), pp.820~827 (2017), 대한한방내과학회
  25. Wong R, "Acupuncture treatment for chemotherapy-induced peripheral neuropathy--a case series. Acupuncture in medicine", Journal of the British Medical Acupuncture Society, 24(2), pp.87~91 (2006)
  26. Bao T, "Acupuncture treatment for bortezomib-induced peripheral neuropathy : a case report", Pain research and treatment, 2011, pp.1~4 (2011)
  27. extract therapy in patients with locally advanced or metastatic pancreatic cancer:A randomised clinical trial on overall survival, "European Journal of Cancer", 2013, 3788~3797
  28. Rasi G, "Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats", International Jounal of Cancer, 57(5), pp.701~705 (1994)
  29. Mastino A, "Combonation therapy with thymosin alpha 1 potentiastes the antitumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis Lung carcinoma in mice", International Journal of Cancer, 50(3), pp.493~499 (1992)
  30. Sharif-Khatibi L, "Hyperthermia induces differentiation without apoptosis in permissive temperatures in human erythroleukaemia cells", Int J Hyperthermia, 23(8), pp.645~655 (2007)
  31. Wust P, "Hyperthermia in combined treatment of cancer", Lancet Oncol, 3(8), pp.487~497 (2002)
  32. 한가진, "췌장암에 대한 국내 한의학 연구 동향 고찰 - 국내 한의학 논문을 중심으로 -", 대한한방내과학회지, 40(1), pp.70~88 (2019), 대한한방내과학회[DOI]

관련 논문AI추천

통합암치료를 적용한 폐전이 동반 췌장암 환자의 장기간 추적관찰 증례보고김지수, 박경덕, 방선휘, 오유나, 정범진, 정유진대한한방내과학회 · 대한한방내과학회지2023 · 제44권 제4호통합 의학 치료로 5년 생존 및 완전 관해에 도달한 췌장암 증례 보고 1례김지수, 박경덕, 방선휘, 오유나, 정범진, 정유진대한한방내과학회 · 대한한방내과학회지2023 · 제44권 제3호전이성 4기 대장암 환자의 한의기반 통합암치료를 통한 증상 호전 증례보고김종희, 박소정, 박지혜, 오현묵, 유화승대한한방내과학회 · 대한한방내과학회지2020 · 제41권 제6호항암화학요법과 병행한 한의기반 통합암치료를 통한 전이성 비소세포폐암 환자의 암성 통증 호전 증례보고박소정, 박지혜, 양재호, 유화승, 조영민, 주한음대한한방내과학회 · 대한한방내과학회지2023 · 제44권 제3호항암화학요법과 한방치료를 병행하여 전환수술이 가능하게 호전된 진행성 위암 환자 1례고은비, 김관일, 신광순, 이범준, 장권준, 정희재, 황우석대한한방내과학회 · 대한한방내과학회지2020 · 제41권 제5호한의기반 통합암치료를 통한 재발성 담낭암 환자의 증상 호전 증례보고고은주, 도성국, 박지혜, 송시연, 유화승, 이연월대한한방내과학회 · 대한한방내과학회지2022 · 제43권 제3호

이 간행물의 다른 논문 (19건)